• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    Celgene Corporation (CELG)

    -NasdaqGS
    100.50 Up 1.32(1.33%) 4:00PM EST
    |After Hours : 100.20 Down 0.30 (0.30%) 6:14PM EST
    Prev Close:99.18
    Open:96.74
    Bid:100.20 x 200
    Ask:100.55 x 100
    1y Target Est:139.29
    Beta:1.86499
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:95.75 - 102.96
    52wk Range:92.98 - 140.72
    Volume:7,306,733
    Avg Vol (3m):5,943,740
    Market Cap:78.96B
    P/E (ttm):51.80
    EPS (ttm):1.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 1.33%78.96B
    JNJDown 0.03%282.14B

    Key Statistics

    Forward P/E (1 yr):13.92
    P/S (ttm):8.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.72
    Quarterly EPS Est (Mar-16) :1.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback